Clinical Trial Update: A Study to Provide Access to Trabectedin in Participants With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Persistent or Recurrent Disease and Who Are Not Expected to Benefit From Currently Available Standard of Care Treatment

View source ↗

Summary

This clinical trial update states that the NCT00210665 study of trabectedin for locally advanced or metastatic soft tissue sarcoma is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Yondelis (trabectedin)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Sarcoma | Status: NO_LONGER_AVAILABLE